Empowering medical decisions through actionable, data-driven genetic intelligence.
Genomiki was incepted with the goal to build solutions to reduce the infant mortality rate. Our innovative genetic screening solutions combine the power of genomics with AI-driven comprehensive interpretation and reporting to help healthcare professionals screen for genetic disorders at every stage of life, from preconception, preimplantation to the newborn stage.
The company has received support through multiple prestigious government-backed innovation and scale-up programs, including SISFS, TIDE 2.0 Scale-Up, and the Startup India Prototype Development Initiative, reflecting strong validation of both the technology and business model.
1. Trademark on product names 2. Patent on newborn screening solution
Winner of Rare Star Awards 2025 Health Innovation Startup. Featured in Forbes India's 100 Most Promising Startup 2025. Selected as top 20 startups out of over 11,000 at WSP3 at NSRCEL, IIM Bangalore. Top emerging Bharat Pitchathon startups by Headstart 2023. Top 20 startups in South-East Asia (top 5 in India) by US-AID, WeScale-Asia Accelerator.
The company is led by a founder and team lead who is a seasoned bioinformatician with nearly two decades of experience in genomic data analysis and clinical applications. The core team comprises highly experienced bioinformaticians, along with experts in sales and operations, ensuring strong technical execution and effective business delivery. The team is further strengthened by an advisory panel of clinical genomics specialists, pediatricians, and other domain experts, providing valuable clinical and strategic guidance.
Founder & Director
Manger Sales
